Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank100
3Y CAGR+37.0%
5Y CAGR+45.1%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+37.0%/yr
vs +21.8%/yr prior
5Y CAGR
+45.1%/yr
Recent deceleration
Acceleration
+15.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $39.38M | +5.6% |
| 2025 | $37.29M | +64.1% |
| 2024 | $22.72M | +48.5% |
| 2023 | $15.30M | +204.0% |
| 2022 | $5.03M | -17.8% |
| 2021 | $6.12M | -33.4% |
| 2020 | $9.19M | +32.1% |
| 2019 | $6.96M | +563.6% |
| 2018 | $1.05M | +152.6% |
| 2017 | $415128.00 | - |